Westside Investment Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.7K | Sell |
250
-925
| -79% | -$84.9K | ﹤0.01% | 861 |
|
|
2025
Q4 | $106K | Buy |
1,175
+405
| +53% | +$38.4K | 0.02% | 387 |
|
|
2025
Q3 | $75.9K | Buy |
770
+525
| +214% | +$52K | 0.01% | 444 |
|
|
2025
Q2 | $22.3K | Buy |
245
+100
| +69% | +$9.67K | ﹤0.01% | 650 |
|
|
2025
Q1 | $16.4K | Hold |
145
| – | – | ﹤0.01% | 606 |
|
|
2024
Q4 | $15.3K | Hold |
145
| – | – | ﹤0.01% | 615 |
|
|
2024
Q3 | $15.7K | Hold |
145
| – | – | ﹤0.01% | 617 |
|
|
2024
Q2 | $15.7K | Hold |
145
| – | – | ﹤0.01% | 589 |
|
|
2024
Q1 | $19.1K | Sell |
145
-100
| -41% | -$12.5K | ﹤0.01% | 526 |
|
|
2023
Q4 | $29.8K | Hold |
245
| – | – | 0.01% | 439 |
|
|
2023
Q3 | $27.5K | Hold |
245
| – | – | 0.01% | 439 |
|
|
2023
Q2 | $35.7K | Sell |
245
-50
| -17% | -$6.79K | 0.01% | 401 |
|
|
2023
Q1 | $38.1K | Hold |
295
| – | – | 0.01% | 393 |
|
|
2022
Q4 | $37 | Sell |
295
-3,196
| -92% | -$371K | ﹤0.01% | 446 |
|
|
2022
Q3 | $364 | Hold |
3,491
| – | – | ﹤0.01% | 302 |
|
|
2022
Q2 | $366 | Sell |
3,491
-115
| -3% | -$13.6K | ﹤0.01% | 295 |
|
|
2022
Q1 | $461 | Sell |
3,606
-597
| -14% | -$72K | ﹤0.01% | 290 |
|
|
2021
Q4 | $518 | Hold |
4,203
| – | – | ﹤0.01% | 279 |
|
|
2021
Q3 | $597 | Sell |
4,203
-119
| -3% | -$17.5K | ﹤0.01% | 270 |
|
|
2021
Q2 | $674 | Sell |
4,322
-87
| -2% | -$14.1K | ﹤0.01% | 257 |
|
|
2021
Q1 | $685 | Hold |
4,409
| – | – | ﹤0.01% | 248 |
|
|
2020
Q4 | $659 | Sell |
4,409
-103
| -2% | -$14.5K | ﹤0.01% | 209 |
|
|
2020
Q3 | $596 | Buy |
4,512
+309
| +7% | +$40.4K | ﹤0.01% | 223 |
|
|
2020
Q2 | $487 | Buy |
4,203
+582
| +16% | +$67.1K | ﹤0.01% | 202 |
|
|
2020
Q1 | $355 | Buy |
+3,621
| New | +$475K | ﹤0.01% | 212 |
|
|
2019
Q2 | $414 | Buy |
+3,626
| New | +$425K | ﹤0.01% | 149 |
|
|
2018
Q4 | $399K | Hold |
3,960
| – | – | 0.15% | 102 |
|
|
2018
Q3 | $502K | Hold |
3,960
| – | – | 0.16% | 85 |
|
|
2018
Q2 | $430K | Hold |
3,960
| – | – | 0.15% | 93 |
|
|
2018
Q1 | $409K | Hold |
3,960
| – | – | 0.22% | 97 |
|
|
2017
Q4 | $485K | Hold |
3,960
| – | – | 0.26% | 83 |
|
|
2017
Q3 | $452K | Hold |
3,960
| – | – | 0.27% | 81 |
|
|
2017
Q2 | $490K | Hold |
3,960
| – | – | 0.32% | 77 |
|
|
2017
Q1 | $462K | Buy |
3,960
+1,673
| +73% | +$190K | 0.22% | 79 |
|
|
2016
Q4 | $255K | Buy |
+2,287
| New | +$245K | 0.17% | 84 |
|
Other funds holding ZBH
VCM
VPM
Westside Investment Management's ZBH Position: Q1 2026 in Review
Westside Investment Management reduced its Zimmer Biomet (ZBH) stake by 79% in Q1 2026, selling an estimated $84.9K and leaving 250 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #861.
Westside Investment Management first reported a position in ZBH in Q4 2016 and has held it in 35 quarters since. The position peaked at $502K in Q3 2018. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Westside Investment Management held 250 shares of Zimmer Biomet worth $22.7K as of Q1 2026.
- Westside Investment Management sold 925 Zimmer Biomet shares in Q1 2026, an estimated $84.9K.
- Zimmer Biomet made up ﹤0.01% of Westside Investment Management's portfolio in Q1 2026, its #861 holding.
- Westside Investment Management first reported a position in Zimmer Biomet in Q4 2016 and has held it in 35 quarters since.
- Westside Investment Management's Zimmer Biomet position peaked at $502K in Q3 2018.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Westside Investment Management's 13F filing for Q1 2026, filed 4 May 2026.